LONDON DAILY ARCHIVE

Pill for Sleep Apnea Shows Promise

Highlighted at the ATS 2026 conference, an experimental oral drug known as AD109 is showing massive potential in treating Obstructive Sleep Apnea by targeting neuromuscular dysfunction of upper airway muscles during sleep.

27 May 2026 · 06:22 UTC